NCT04193189 B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B Status COMPLETED Phase PHASE3
NCT04188223 Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children Status COMPLETED Phase PHASE1
NCT04179786 A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ Status COMPLETED Phase PHASE4
NCT04177485 Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda Status COMPLETED Phase NA
NCT04114890 Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. Status COMPLETED Phase PHASE2
NCT04109625 Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening Status COMPLETED Phase NA
NCT04083157 Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients Status COMPLETED Phase PHASE2/PHASE3
NCT04075201 Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) Status COMPLETED Phase PHASE1
NCT04073459 Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants Status UNKNOWN Phase PHASE2
NCT04059198 Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus Status TERMINATED Phase PHASE2
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule Status COMPLETED Phase NA
NCT04023721 Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor Status TERMINATED Phase PHASE2
NCT03977987 Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission Status COMPLETED Phase N/A
NCT03973502 Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD Status UNKNOWN Phase NA
NCT03957629 Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis Status UNKNOWN Phase NA
NCT03933384 Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B Status RECRUITING Phase PHASE4
NCT03932513 Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients Status TERMINATED Phase PHASE2
NCT03931239 The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks Status COMPLETED Phase NA
NCT03920618 Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF Status RECRUITING Phase NA